|
Concord Biotech to discuss results> |
|
Concord Biotech schedules AGM> |
|
Concord Biotech fixes record date for final dividend> |
|
Concord Biotech’s formulation facility clears regulatory inspections by Kenya's PPB & Uganda's NDA> |
|
Concord Biotech's Unit II formulations unit successfully clears PPB and NDA inspection> |
|
Concord Biotech's Limbasi unit clears Brazilian health regulatory inspection> |
|
Concord Biotech completes ANVISA inspection at Limbasi API facility> |
|
Concord Biotech rallies after USFDA approval for Tofacitinib tablets> |
|
Concord Biotech receives USFDA approval for Tofacitinib Tablets> |
|
Concord Biotech gains after receiving USFDA approval for Mycophenolate Mofetil> |